Update on Managing the Risks of Exposure to Lentiviral and Retroviral Vectors

Gary R Fujimoto¹, Dawn P Wooley, Karen B Byers+4

• ¹From the Occupational and Internal Medicine Consultant, Los Altos, California (G.R.F.); Department of Neuroscience, Cell Biology, and Physiology, Wright State University, Dayton, Ohio (D.P.W.); Dana-Farber Cancer Institute, Boston, Massachusetts (K.B.B.); Division of Infectious Diseases, Department of Medicine, and Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California (O.O.Y.); Division of Occupational Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.J.B.); Occupational Health Programs at the Boston Children's Hospital and Dana Farber Cancer Institute, Research Occupational Health Program and the National Emerging Infectious Disease Laboratories, Boston University, and the Harvard T.H. Chan School of Public Health, Boston, Massachusetts (T.H.W.); and Department of Occupational and Environmental Health, University of California Irvine, Irvine, California (T.W.H.).